Now in network with most major insurance providers – Click to learn more
Menu
Migraines are a debilitating neurological condition that affects millions of people worldwide. Characterized by severe and recurring headaches, migraines can cause intense pain, sensitivity to light and sound, nausea, and even vomiting. These symptoms can last for hours or even days, significantly impacting an individual’s quality of life and ability to function. Recent studies have also highlighted ketamine’s effectiveness in alleviating migraine symptoms.
Ketamine works by modulating the glutamate system in the brain, which is involved in pain processing. It acts as an N-methyl-D-aspartate (NMDA) receptor antagonist, blocking the transmission of pain signals.
The unique mechanism of action that ketamine uses sets it apart from traditional migraine medications, which mainly target vasodilation or inflammation. By directly targeting the brain’s pain pathways, ketamine therapy offers a novel approach to migraine treatment.
A condition that can develop as a result of over-reliance on acute migraine medications. By breaking the cycle of medication dependence, ketamine therapy can provide long-lasting relief for individuals suffering from chronic migraines.
Additionally, ketamine therapy offers a potential alternative for patients who are unable to tolerate or have contraindications to other migraine medications. Its rapid onset of action and potential long-lasting effects make it an attractive option for those seeking immediate relief from debilitating migraines.
Several studies have demonstrated the effectiveness of ketamine therapy in reducing the frequency, intensity, and duration of migraines. In a 2019 study published in the Journal of Headache and Pain, researchers found that ketamine significantly reduced the number of migraine attacks and decreased pain intensity in patients who had previously not responded well to standard treatments. Another study published in Pain Medicine in 2020 showed that intravenous ketamine infusion resulted in a significant reduction in migraine pain and disability.
Please fill out your information below, and we will schedule a phone consultation to discuss if ketamine therapy is right for you.
If you want to contact us directly, you can email us at info@questketamineclinics.com, call us at (425) 654-5433 or text us at (206) 589-5958. Please leave your name, contact information, and the best time(s) to reach you, and we will get back to you as soon as possible. We Look forward to speaking with you!
